DOW JONES23,719.37+285.80 1.22%
S&P 5002,789.82+39.84 1.45%
NASDAQ8,153.58+62.67 0.77%

Sidoti & Co. Upgrades LeMaitre Vascular to Buy, Announces $38 Price Target

Sidoti & Co. analyst James Sidoti upgrades LeMaitre Vascular (NASDAQ:LMAT) from Neutral to Buy and announces $38 price target.

Benzinga · 03/16/2020 13:04

Sidoti & Co. analyst James Sidoti upgrades LeMaitre Vascular (NASDAQ:LMAT) from Neutral to Buy and announces $38 price target.